BioPharmSignal logoBioPharmSignal

Biotech News

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

Artivion (AORT)ArtivionEarnings

ATLANTA, April 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2026 financial results will be released on Thursday, May 7, 2026, after the market closes.

Open original release

Related news

AORTArtivion2026-05-07 20:05 EST

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

CVRXCVRx2026-04-27 20:30 EST

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

STIMNeuronetics2026-04-21 12:30 EST

Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

PAVMPAVmed2026-05-14 12:00 EST

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

ICCMIceCure Medical2026-05-12 12:30 EST

IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America

CVRXCVRx2026-05-11 20:05 EST

CVRx Reports First Quarter 2026 Financial and Operating Results

DNLIDenali Therapeutics2026-05-07 20:01 EST

Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

SGHTSight Sciences2026-05-06 20:05 EST

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

ICCMIceCure Medical2026-05-06 12:30 EST

IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026

STIMNeuronetics2026-05-05 11:50 EST

Neuronetics Reports First Quarter 2026 Financial and Operating Results

View all latest news

Artivion

Artivion is a medical device company focused on cardiovascular surgery, aortic repair, and preservation technologies. Its products are used in complex cardiac and vascular procedures.

Recent company news

AORTArtivion2026-05-18 11:00 EST

Artivion Completes Acquisition of Endospan Ltd.

AORTArtivion2026-05-07 20:05 EST

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

AORTArtivion2026-04-23 20:15 EST

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

AORTArtivion2026-04-07 11:00 EST

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

AORTArtivion2026-03-03 21:10 EST

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Stock data

Close
26.10 USD
Market cap
991.26M USD
Exchange
NYSE
Sector
MedTech
Location
United States